ONCASPAR (Pegaspargase)

  • Brand Name: ONCASPAR
  • Active Ingredient: Pegaspargase
  • Dosage Form: 3,750 IU /5 ml Single-Use Vials
  • Manufacturer Name: Baxalta US Inc.
Get Price


ONCASPAR (Pegaspargase) Uses

Pegaspargase specifically is an asparagine specific enzyme used as a component of a multi-agent chemotherapeutic regimen to treat pediatric and adult patients with:

  • First-line acute lymphoblastic leukemia.
  • Acute lymphoblastic leukemia and hypersensitivity to asparaginase.

Dosage: The recommended pegaspargase dose for patients up to and including 21 years of age is 2,500 International Units/m2, and for adult patients aged more than 21 years is 2000 International Units/m2 intramuscularly or intravenously no more frequently than every 2 weeks.

Side Effects: The most commonly reported pegaspargase side effects are:

  • Hypoalbuminemia
  • Elevated transaminase
  • Febrile neutropenia
  • Hypertriglyceridemia
  • Hyperglycemia
  • Bilirubin increased
  • Pancreatitis
  • Abnormal clotting studies
  • Embolic and thrombotic events
  • Hypersensitivity

Warnings and Precautions:

  • Pancreatitis may occur in patients receiving oncaspar 3750. Hemorrhagic or necrotizing pancreatitis with fatal outcomes have been reported.
  • Glucose intolerance can appear in patients receiving pegaspargase. In a few cases, glucose intolerance is irreversible. Serum glucose should be monitored.
  • Patients with pegaspargase injection should be assessed for symptoms of hemorrhage with coagulation parameters including PTT, PT, fibrinogen.
  • Assess bilirubin and transaminases at least weekly during pegaspargase treatment at least 6 weeks after the last dose.
  • On behalf of published literature studies in pregnant animals, oncaspar 3750 can be responsible for causing fetal harm in cases administered to a pregnant woman.
  • Patients are advised to notify their healthcare practitioner promptly in the event of a pregnancy, or in case pregnancy is suspected during pegaspargase injection treatment.

More info

Storage: Pegaspargase should be stored at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not shake or freeze the product. Unopened vials of pegaspargase may be stored at room temperature 15°C to 25°C (59°F to 77°F) for not more than 48 hours. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the ONCASPAR at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the ONCASPAR Injections. Buying Procedure: In order to buy ONCASPAR, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp +919310090915 or an Email to us at: info@theindianpharma.com along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusion: Pegaspargase, as part of multidrug chemotherapy, is a cost-effective option in the treatment of newly diagnosed patients with ALL. This therapy is recommended for treating ALL in children, young people and adults with untreated, newly diagnosed disease.


What is ONCASPAR? ONCASPAR is a medication aimed for treating acute lymphoblastic leukemia (ALL). How is ONCASPAR supplied? ONCASPAR is supplied as 3,750 IU /5 ml single-use vials for intramuscularly or intravenously infusion. In how many countries ONCASPAR is approved for marketing? ONCASPAR is available/approved in the USA and Europe. We can help you to access it in India. How can I get ONCASPAR in India? ONCASPAR is a prescription-only drug and is not approved for marketing in India. The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations. Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –info@theindianpharma.com We facilitate by-
  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable sources in the USA, Europe and Japan.
  • Ensuring 100% transparency.
ONCASPAR can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India. The Indian Pharma can facilitate the supply of ONCASPAR (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement. The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees. Can I get ONCASPAR even if I am not based in India? Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Indian Pharma (IP) can help patients in accessing/importing ONCASPAR, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country. Send your enquiry to find –
  • ONCASPAR in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
  • ONCASPAR in the United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
  • ONCASPAR in North America – Mexico.
  • ONCASPAR in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
  • ONCASPAR in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
  • ONCASPAR in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
  • ONCASPAR in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
  • ONCASPAR in Australia and New Zealand.
How do I contact The Indian Pharma? You can use a different channel to contact The Indian Pharma (TIP) Tele & Mobile: You can reach us on +91 9310090915 or +91-120-4080562. Email: We can also address your enquiries if sent directly to info@theindianpharma.com. We will respond within 24 hours along with pegaspargase price & procurement details after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working day after receiving your query form.


What information do you need to help patient in assisting documentation for ONCASPAR import for personal use? We will require the following documents to help in documentation for Named-Patient import
  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.